Evaluation of Stigma and Related Factors in Fibromyalgia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04274036|
Recruitment Status : Recruiting
First Posted : February 18, 2020
Last Update Posted : February 18, 2020
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||108 participants|
|Official Title:||Evaluation of Stigma and Related Factors in Fibromyalgia Patients|
|Actual Study Start Date :||February 13, 2020|
|Estimated Primary Completion Date :||May 31, 2020|
|Estimated Study Completion Date :||May 31, 2020|
Fibromyalgia patients diagnosed according to the 2016 American College of Rheumatology criteria.
Healthy controls without pain or chronic illness
- Visual Analog Scale [ Time Frame: Baseline ]A scale to measure pain which "0" shows no pain and "10" shows worst pain ever
- Discomfort Intolerance Scale [ Time Frame: Baseline ]The Discomfort Intolerance Scale is brief, self-report index of the degree to which individuals tolerate physical discomfort including pain. Items for this scale were developed by experts in pain and anxiety. Participants rate the questions on a scale ranging from 0 (not at all like me) to 6 (extremely like me). Higher points show worst outcomes.
- The Distress Tolerance Scale [ Time Frame: Baseline ]Distress tolerance is defined as the capacity to experience and withstand negative psychological states. Distress may be the result of cognitive or physical processes but manifests in an emotional state often characterized by action tendencies to alleviate the emotional experience. Distress tolerance is considered a meta-emotion construct that consists of one's evaluations and expectations of experiencing negative emotional states in respect to tolerability and aversiveness, appraisal and acceptability, tendency to absorb attention and disrupt functioning, and regulation of emotions, specifically, the consequent strength of action tendencies to either avoid or immediately attenuate the experience
- Fibromyalgia Impact Questionnaire - Revised [ Time Frame: Baseline ]The revised Fibromyalgia Impact Questionnaire has 21 individual questions All questions are based on an 11-point numeric rating scale of 0 to 10, with 10 being 'worst'.
- Stigma Scale for Chronic Illness [ Time Frame: Baseline ]The stigma scale consists of 24 items. Item scores range from 1 (never) to 5 (always). A summary index is calculated by adding all scores, ranging from 24 to 120, with higher scores reflecting the worst stigmatization.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04274036
|Contact: Mehmet Akif Guler, M.D.||+firstname.lastname@example.org|
|Gaziosmanpasa Taksim Research and Education Hospital||Recruiting|
|Contact: Mehmet Akif Güler, Dr. +905054930098 email@example.com|